Corrigendum to 'secoisolariciresinol diglucoside inhibits adipogenesis through the AMPK pathway’ [European Journal of Pharmacology (2018) 820:235-244](S0014299917308324)(10.1016/j.ejphar.2017.12.038)

Jong Wook Kang, Jinbong Park, Hye Lin Kim, Yunu Jung, Dong Hyun Youn, Seona Lim, Gahee Song, Hyewon Park, Jong Sik Jin, Hyun Jeong Kwak, Jae Young Um

Research output: Contribution to journalComment/debate

Abstract

The authors regret stating incorrect reference number of the funding sources. The authors re-state the Acknowledgment statement as below by this Corrigendum. The authors would like to apologise for any inconvenience caused. This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2015R1A41042399, 2017M3A9E4065333, 2016R1D1A1B03930518). DOI of original article: https://doi.org/10.1016/j.ejphar.2017.12.038

Original languageEnglish
Pages (from-to)139
Number of pages1
JournalEuropean Journal of Pharmacology
Volume830
DOIs
Publication statusPublished - 5 Jul 2018

Bibliographical note

Publisher Copyright:
© 2017 Elsevier B.V.

Fingerprint

Dive into the research topics of 'Corrigendum to 'secoisolariciresinol diglucoside inhibits adipogenesis through the AMPK pathway’ [European Journal of Pharmacology (2018) 820:235-244](S0014299917308324)(10.1016/j.ejphar.2017.12.038)'. Together they form a unique fingerprint.

Cite this